510(k) Report

510(k) · Cleared

Cleared

Cerament Bone Void Filler

K051951510(k) TraditionalCleared Sep 28, 200572-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bonesupport AB · MQV Filler, Bone Void, Calcium Compound

Cleared on Sep 28, 2005 as substantially equivalent to K024336 (Wrightmedicaltechnologyinc, 2003) and 5 other predicates after a 72-day review. Its family tree reaches back 4 generations to 1996. 10 later devices descend from it.

Decided
Sep 28, 2005
Review
72 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
6

Its longest line of descent runs back 4 generations to K960978 (1996). 12 ancestors in all, the oldest K910432 (1991). 10 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 2 other ancestors2002: 1 other ancestor2001: 1 other ancestor1996: 1 other ancestor1991: 1 other ancestor2000: 1 other ancestor1997: 1 other ancestor2009: 2 descendants cleared2008: 1 descendant cleared2022: 2 descendants cleared2020: 1 descendant cleared2013: 1 descendant cleared2023: 2 descendants cleared2021: 1 descendant clearedK960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K030131 · Ossatura BCP Bone Void Filler · Isotis NV · 2003K033722 · Apapore Bone Graft Substitute · Apatech, Ltd. · 20041990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 5 other ancestors2 generations back: 1 other ancestor3 generations back: 1 other ancestor4 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 4 descendants4 generations forward: 1 descendant K033722 · Apapore Bone Graft Substitute · Apatech, Ltd. · 2004K030131 · Ossatura BCP Bone Void Filler · Isotis NV · 2003K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 19960
  1. Root · 4 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 3 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 2 generations backK030131 Ossatura BCP Bone Void FillerIsotis NV · 2003
  4. 1 generation backK033722 Apapore Bone Graft SubstituteApatech, Ltd. · 2004
  5. This deviceK051951 Cerament Bone Void FillerBonesupport AB · 2005
  6. Descendant · cites it directly · 6 of its ownK073316 Cerament Bone Void Filler, Model A0210Bonesupport AB · 2008
  7. Descendant · 2 generations on · 3 of its ownK201535 Cerament Bone Void FillerBonesupport AB · 2020
  8. Descendant · 3 generations on · 2 of its ownK212083 Tactoset Injectable Bone SubstituteAnika Therapeutics, Inc. · 2021
  9. Descendant · cites it directly · 2 of its ownK071004 Osteocrete Bone Void FillerBone Solutions, Inc. · 2009
  10. Descendant · 4 generations on · 1 of its ownK223915 TactosetAnika Therapeutics, Inc. · 2023

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2008: 12009: 22013: 12020: 12021: 12022: 22023: 2
2008high 2 (2009) · low 0 (2010)2026

Most influential descendants

Showing 5 of 10 · See all
  • K073316Cerament Bone Void Filler, Model A0210Bonesupport AB · 2008 · cites it directly6descendants
  • K201535Cerament Bone Void FillerBonesupport AB · 2020 · 2 generations on3descendants
  • K212083Tactoset Injectable Bone SubstituteAnika Therapeutics, Inc. · 2021 · 3 generations on2descendants
  • K071004Osteocrete Bone Void FillerBone Solutions, Inc. · 2009 · cites it directly2descendants
  • K223915TactosetAnika Therapeutics, Inc. · 2023 · 4 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−3K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−2K030131Ossatura BCP Bone Void FillerIsotis NV2003—
−1K033722Apapore Bone Graft SubstituteApatech, Ltd.2004—
0 (this device)K051951Cerament Bone Void FillerBonesupport AB2005—
+1K073316Cerament Bone Void Filler, Model A0210Bonesupport AB2008—
+2K201535Cerament Bone Void FillerBonesupport AB2020—
+3K212083Tactoset Injectable Bone SubstituteAnika Therapeutics, Inc.2021—
+1K071004Osteocrete Bone Void FillerBone Solutions, Inc.2009—
+4K223915TactosetAnika Therapeutics, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
199710
200010
200110
200210
200320

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200920
201310
202010
202110
202220
202320
FIG. 1 — Lineage of K051951, 1996–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K024336Miig II Bone Graft Substitute
Summary page 1
…ols per 21 CFR 8883045 PREDICATE DEVICES: 510(k) Number Trade or Proprietary or Model Name Manufacturer K024336 1 MIIG II ™ 1…
Wrightmedicaltechnologyinc2003—
*K010532Osteoset BVF Kit
Summary page 1
…er K024336 1 MIIG II ™ 1 Wright Medical Technology K010532 2 Osteoset BVF Kit 2…
Wrightmedicaltechnologyinc2001—
*K022622Cem-Ostetic, Models Cemo-020O, Cemo-05P, Cemo-10P, Cemo-20P, and Cemo-30P
Summary page 1
…ogy K010532 2 Osteoset BVF Kit 2 Wright Medical Technology K022622 3 Cem-Ostetic™ 3…
Berkeley Advanced Biomaterials, Inc.2003—
*K023862Norian XR Calcium Phosphate Bone Void Filler
Summary page 1
…K022622 3 Cem-Ostetic™ 3 Berkley Advanced Biomaterials K023862 4 Norian® XR 4…
Synthes (Usa)2002—
*K033722Apapore Bone Graft Substitute
Summary page 1
…ced Biomaterials K023862 4 Norian® XR 4 Synthes Inc. K033722 5 ApaPore® 5…
Apatech, Ltd.2004—
*K961511Hapset Hydroxylapatite Bone Graft Plaster
Summary page 1
…Synthes Inc. K033722 5 ApaPore® 5 Apa Tech Limited K961511 6 Hapset 6…
Lifecore Biomedical, Inc.1996—

Also cleared against K024336: 6 other devices →

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K073316Cerament Bone Void Filler, Model A0210Bonesupport AB20086
K071004Osteocrete Bone Void FillerBone Solutions, Inc.20092

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 5 companies; a new generation was cleared every 2.3 years on median.
  • None of the 12 ancestors has a recall.
  • Of its descendants, K073316 (Bonesupport AB, 2008) has gone furthest, with 6 descendants of its own.
  • 6 other devices also cite its predicate K024336.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Cerament™ is a ceramic bone void filler intended only for orthopedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. Cerament™ is indicated to be injected into bony voids or gaps in the skeletal system, i.e. extremities, spine, and pelvis. These defects may be surgically created osseous defects or osseous defects from traumatic injury to the bone. Cerament™ provides a bone void filler that resorbs and is replaced by bone during the healing process

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051951: Cerament Bone Void Filler.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K051951

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026